Rare Disease
-
Takeda and UNGCNI join hands to strengthen access to rare disease treatment in India
Bangalore, 9 May 2022: In November 2021, Takeda Pharmaceutical Company Limited, a global values-based, R&D-driven biopharmaceutical leader, together with UNGCNI…
Read More »